<DOC>
	<DOCNO>NCT00002844</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining chemotherapy bone marrow transplantation may allow doctor give high dos chemotherapy drug kill cancer cell . PURPOSE : Phase II trial study effectiveness bone marrow transplantation treat patient chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Bone Marrow Transplantation Treating Patients With Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : Examine potential role high dose cyclophosphamide , total body irradiation bone marrow transplantation patient chronic lymphocytic leukemia high risk disease progression . OUTLINE : Patients receive daily intravenous infusion cyclophosphamide two day , follow total body irradiation four daily exposure . After completion total body irradiation , allogeneic autologous bone marrow infuse intravenously . PROJECTED ACCRUAL : 50 patient expect accrued .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Chronic lymphocytic leukemia ( CLL ) patient initial relapse achieve complete partial remission fludarabine therapy initial relapse progression Prolymphocytic leukemia first remission relapse Patients 1565 year old lack HLAidentical sibling eligible autologous BM transplantation Patients 1650 year old HLA identical one antigen mismatch related donor eligible allogeneic BM transplantation PATIENT CHARACTERISTICS : Age : 1565 ( See Disease Characteristics ) Performance status : Zubrod 2 Hematopoietic : Not specify Hepatic : Bilirubin great 1.5 mg/dL Renal : Creatinine great 1.5 mg/dL Cardiovascular : Cardiac ejection fraction least 50 % Pulmonary : DLCO least 50 % predict Other : No severe concomitant medical psychiatric illness PRIOR CONCURRENT THERAPY : No extensive prior radiotherapy would prevent administration total body radiation Patients may also participate study MDADM92082 retroviral gene mark autologous marrow blood cell</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>refractory chronic lymphocytic leukemia</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Cytoxan</keyword>
	<keyword>Neosar</keyword>
	<keyword>Bone Marrow Transplantation</keyword>
	<keyword>total body irradiation</keyword>
	<keyword>chronic lymphocytic leukemia</keyword>
	<keyword>allogeneic</keyword>
	<keyword>autologous</keyword>
</DOC>